Celltrion, Inc. (KRX:068270)
South Korea · Delayed Price · Currency is KRW 199,300
+4,300 (2.21%)
At close: Aug 7, 2026
Celltrion Market Cap
Celltrion has a market cap or net worth of 45.7 trillion as of August 7, 2026. Its market cap has increased by 16.15% in one year.
Market Cap
45.70T
Enterprise Value
48.30T
Revenue
4.47T
Ranking
n/a
PE Ratio
36.33
Stock Price
199,300.00
ChartMarket Cap Chart
Since August 20, 2008, Celltrion's market cap has increased from 103.80B to 45.70T, an increase of 43,930.33%. That is a compound annual growth rate of 40.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 45.70T | 15.41% |
| Dec 30, 2025 | 39.60T | -1.89% |
| Dec 30, 2024 | 40.37T | 44.32% |
| Dec 28, 2023 | 27.97T | 21.61% |
| Dec 29, 2022 | 23.00T | -16.64% |
| Dec 30, 2021 | 27.59T | -43.68% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 72.03T |
| ALTEOGEN | 21.24T |
| Samsung Epis Holdings | 10.22T |
| SK Biopharmaceuticals | 6.69T |
| HLB Co., Ltd. | 4.96T |
| ABL Bio | 4.85T |
| Peptron | 4.24T |
| LigaChem Biosciences | 4.17T |